Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89263753 | 8926375 | 3 | F | 201210 | 20160829 | 20121127 | 20160906 | EXP | JP-GLAXOSMITHKLINE-B0841857A | GLAXOSMITHKLINE | 2014;129(1):24-25 | 85.92 | YR | F | Y | 55.00000 | KG | 20160906 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89263753 | 8926375 | 1 | PS | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 1000 MG, TID | 9000 | MG | Y | 20487 | 1000 | MG | TABLET | TID | |||
| 89263753 | 8926375 | 2 | SS | LASIX | FUROSEMIDE | 1 | Oral | 10 MG, QOD | Y | 0 | 10 | MG | QOD | ||||||
| 89263753 | 8926375 | 3 | C | Atorvastatin | ATORVASTATIN | 1 | 10 MG, QD | 0 | 10 | MG | QD | ||||||||
| 89263753 | 8926375 | 4 | C | Atorvastatin | ATORVASTATIN | 1 | 10 MG, QD | 0 | 10 | MG | QD | ||||||||
| 89263753 | 8926375 | 5 | C | Merislon | BETAHISTINE MESILATE | 1 | 12 MG, BID | 0 | 12 | MG | BID | ||||||||
| 89263753 | 8926375 | 6 | C | Methycobal | METHYLCOBALAMIN | 1 | 0.5 MG, BID | 0 | .5 | MG | BID | ||||||||
| 89263753 | 8926375 | 7 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 2.5 MG, QD | 0 | 2.5 | MG | QD | ||||||||
| 89263753 | 8926375 | 8 | C | Loxonin | LOXOPROFEN SODIUM | 1 | UNK | 0 | |||||||||||
| 89263753 | 8926375 | 9 | C | GENTAMICIN SULFATE. | GENTAMICIN SULFATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 89263753 | 8926375 | 1 | Herpes zoster |
| 89263753 | 8926375 | 2 | Hypertension |
| 89263753 | 8926375 | 3 | Hyperlipidaemia |
| 89263753 | 8926375 | 5 | Dizziness |
| 89263753 | 8926375 | 6 | Neuralgia |
| 89263753 | 8926375 | 7 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 89263753 | 8926375 | OT |
| 89263753 | 8926375 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 89263753 | 8926375 | Abnormal behaviour | |
| 89263753 | 8926375 | Acute kidney injury | |
| 89263753 | 8926375 | Cerebral atrophy | |
| 89263753 | 8926375 | Dehydration | |
| 89263753 | 8926375 | Disorientation | |
| 89263753 | 8926375 | Dysarthria | |
| 89263753 | 8926375 | ECG signs of myocardial ischaemia | |
| 89263753 | 8926375 | Electroencephalogram abnormal | |
| 89263753 | 8926375 | Gait disturbance | |
| 89263753 | 8926375 | Mental disorder | |
| 89263753 | 8926375 | Nuclear magnetic resonance imaging brain abnormal | |
| 89263753 | 8926375 | Oliguria | |
| 89263753 | 8926375 | Overdose | |
| 89263753 | 8926375 | Protein urine present | |
| 89263753 | 8926375 | Renal impairment | |
| 89263753 | 8926375 | Speech disorder | |
| 89263753 | 8926375 | Toxic encephalopathy | |
| 89263753 | 8926375 | Urine output decreased | |
| 89263753 | 8926375 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 89263753 | 8926375 | 1 | 20121027 | 20121030 | 0 | |
| 89263753 | 8926375 | 2 | 20121029 | 0 | ||
| 89263753 | 8926375 | 3 | 20121029 | 0 | ||
| 89263753 | 8926375 | 4 | 20121106 | 0 | ||
| 89263753 | 8926375 | 5 | 20121030 | 0 | ||
| 89263753 | 8926375 | 6 | 20121030 | 0 | ||
| 89263753 | 8926375 | 7 | 20121030 | 0 |